BAP1 and nonpapillary renal cell carcinoma: Compared with ccRCC patients without VTT and the corresponding data in the KIRC, we found a trend of an increased prevalence of BAP1 alterations in both VTT and their matched primary tumor tissues, and alterations of BAP1 have been widely regarded as an unfavorable prognosis biomarker in ccRCC (20).